Nov 27 (Reuters) - Xenon Pharmaceuticals said on Monday its experimental drug to treat severe major depressive disorder had failed to meet the main goal in a mid-stage study. (Reporting by Mariam Sunny in Bengaluru; Editing by Pooja Desai)
There's a much more popular AI stock on Capitol Hill than the leading AI chip maker.
Nancy Pelosi's husband Paul Pelosi uses an investing strategy that lowers upfront costs.
A month after a higher state minimum wage for fast-food workers went into effect, consumers picking up burgers and burritos at chains in the Golden State grapple with prices rising at a faster clip than in other states.
In addition to economic and earnings news, inflation and geopolitical worries will have roles to play.
If you have inherited retirement assets, have a Roth 401(k) or want to give retirement money to charity, you may be impacted by tweaks to this year’s rules for RMDs.
The $50 million purchase could turn into Nvidia's biggest investment.
Whether or not these stocks hit analysts' price targets, they all should be attractive to investors seeking great income and solid growth.
Here's what could happen next to Alphabet shares.
The tobacco giant will soon be allowed to sell a proven product in a proven market.
The number probably isn't anywhere near what you think it is.